VSee Health, Inc. (NASDAQ: VSEE) Stock Competitors & Peer Comparison
See VSEE's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for VSEE and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VSEE | $1.15 | -4.17% | 931.2K | -2.58 | -$0.45 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| TEM | $76.05 | +7.98% | 13.5B | -152.08 | -$0.50 | N/A |
| BTSGU | $212.10 | -1.95% | 13.4B | 129.05 | $1.71 | N/A |
| BTSG | $67.15 | +1.96% | 13.4B | 39.26 | $1.71 | N/A |
| HNGE | $115.76 | -0.19% | 9.3B | 61.90 | $1.87 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $103.63 | +0.16% | 8.6B | 24.20 | $4.28 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| DOCS | $32.51 | -2.02% | 5.8B | 21.25 | $1.53 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
VSEE vs GEHCV Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas GEHCV's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to GEHCV's ROE of +0.20%. Regarding short-term risk, VSEE is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check GEHCV's competition here
Tempus AI, Inc. (NASDAQ: TEM)
VSEE vs TEM Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, TEM has a market cap of 13.5B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while TEM trades at $76.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas TEM's P/E ratio is -152.08. In terms of profitability, VSEE's ROE is -4.01%, compared to TEM's ROE of -0.41%. Regarding short-term risk, VSEE is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check TEM's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
VSEE vs BTSGU Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, BTSGU has a market cap of 13.4B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while BTSGU trades at $212.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas BTSGU's P/E ratio is 129.05. In terms of profitability, VSEE's ROE is -4.01%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, VSEE is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check BTSGU's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
VSEE vs BTSG Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, BTSG has a market cap of 13.4B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while BTSG trades at $67.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas BTSG's P/E ratio is 39.26. In terms of profitability, VSEE's ROE is -4.01%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, VSEE is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check BTSG's competition here
Hinge Health, Inc. (NYSE: HNGE)
VSEE vs HNGE Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, HNGE has a market cap of 9.3B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while HNGE trades at $115.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas HNGE's P/E ratio is 61.90. In terms of profitability, VSEE's ROE is -4.01%, compared to HNGE's ROE of +0.50%. Regarding short-term risk, VSEE is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check HNGE's competition here
Signify Health, Inc. (NYSE: SGFY)
VSEE vs SGFY Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SGFY's P/E ratio is 70.91. In terms of profitability, VSEE's ROE is -4.01%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, VSEE is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
VSEE vs HQY Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, HQY has a market cap of 8.6B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while HQY trades at $103.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas HQY's P/E ratio is 24.20. In terms of profitability, VSEE's ROE is -4.01%, compared to HQY's ROE of +0.11%. Regarding short-term risk, VSEE is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check HQY's competition here
R1 RCM Inc. (NASDAQ: RCM)
VSEE vs RCM Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, RCM has a market cap of 6B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas RCM's P/E ratio is -102.21. In terms of profitability, VSEE's ROE is -4.01%, compared to RCM's ROE of +0.00%. Regarding short-term risk, VSEE is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
VSEE vs DOCS Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, DOCS has a market cap of 5.8B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while DOCS trades at $32.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas DOCS's P/E ratio is 21.25. In terms of profitability, VSEE's ROE is -4.01%, compared to DOCS's ROE of +0.15%. Regarding short-term risk, VSEE is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
VSEE vs WAY Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, WAY has a market cap of 5.5B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while WAY trades at $28.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas WAY's P/E ratio is 18.77. In terms of profitability, VSEE's ROE is -4.01%, compared to WAY's ROE of +0.03%. Regarding short-term risk, VSEE is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check WAY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
VSEE vs HTFL Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, HTFL has a market cap of 4.6B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while HTFL trades at $52.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas HTFL's P/E ratio is -26.07. In terms of profitability, VSEE's ROE is -4.01%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, VSEE is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
VSEE vs ONEM Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas ONEM's P/E ratio is -7.77. In terms of profitability, VSEE's ROE is -4.01%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, VSEE is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
VSEE vs PRVA Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, PRVA has a market cap of 3.1B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while PRVA trades at $24.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas PRVA's P/E ratio is 116.33. In terms of profitability, VSEE's ROE is -4.01%, compared to PRVA's ROE of +0.05%. Regarding short-term risk, VSEE is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check PRVA's competition here
Certara, Inc. (NASDAQ: CERT)
VSEE vs CERT Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CERT has a market cap of 1.8B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CERT trades at $12.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CERT's P/E ratio is 30.07. In terms of profitability, VSEE's ROE is -4.01%, compared to CERT's ROE of -0.06%. Regarding short-term risk, VSEE is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CERT's competition here
Omnicell, Inc. (NASDAQ: OMCL)
VSEE vs OMCL Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, OMCL has a market cap of 1.7B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while OMCL trades at $37.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas OMCL's P/E ratio is 19.57. In terms of profitability, VSEE's ROE is -4.01%, compared to OMCL's ROE of +0.04%. Regarding short-term risk, VSEE is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check OMCL's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
VSEE vs NXGN Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas NXGN's P/E ratio is -266.00. In terms of profitability, VSEE's ROE is -4.01%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, VSEE is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check NXGN's competition here
Teladoc Health, Inc. (NYSE: TDOC)
VSEE vs TDOC Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while TDOC trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas TDOC's P/E ratio is -10.17. In terms of profitability, VSEE's ROE is -4.01%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, VSEE is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check TDOC's competition here
Agiliti, Inc. (NYSE: AGTI)
VSEE vs AGTI Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas AGTI's P/E ratio is -71.79. In terms of profitability, VSEE's ROE is -4.01%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, VSEE is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
VSEE vs GDRX Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while GDRX trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas GDRX's P/E ratio is 11.00. In terms of profitability, VSEE's ROE is -4.01%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, VSEE is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check GDRX's competition here
Omada Health (NASDAQ: OMDA)
VSEE vs OMDA Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, OMDA has a market cap of 922.8M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while OMDA trades at $15.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas OMDA's P/E ratio is 65.54. In terms of profitability, VSEE's ROE is -4.01%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, VSEE is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check OMDA's competition here
HealthStream, Inc. (NASDAQ: HSTM)
VSEE vs HSTM Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, HSTM has a market cap of 883M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while HSTM trades at $28.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas HSTM's P/E ratio is 40.08. In terms of profitability, VSEE's ROE is -4.01%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, VSEE is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
VSEE vs CCLDO Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CCLDO's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to CCLDO's ROE of +0.24%. Regarding short-term risk, VSEE is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CCLDO's competition here
Phreesia, Inc. (NYSE: PHR)
VSEE vs PHR Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, PHR has a market cap of 783.6M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while PHR trades at $12.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas PHR's P/E ratio is 45.09. In terms of profitability, VSEE's ROE is -4.01%, compared to PHR's ROE of +0.03%. Regarding short-term risk, VSEE is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
VSEE vs MPLN-WT Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, VSEE is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check MPLN-WT's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
VSEE vs SOPH Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SOPH has a market cap of 607.8M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SOPH trades at $7.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SOPH's P/E ratio is -6.43. In terms of profitability, VSEE's ROE is -4.01%, compared to SOPH's ROE of -1.33%. Regarding short-term risk, VSEE is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check SOPH's competition here
Accolade, Inc. (NASDAQ: ACCD)
VSEE vs ACCD Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas ACCD's P/E ratio is -3.08. In terms of profitability, VSEE's ROE is -4.01%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, VSEE is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check ACCD's competition here
NRC Health (NASDAQ: NRC)
VSEE vs NRC Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, NRC has a market cap of 572M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while NRC trades at $25.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas NRC's P/E ratio is 31.54. In terms of profitability, VSEE's ROE is -4.01%, compared to NRC's ROE of +1.03%. Regarding short-term risk, VSEE is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check NRC's competition here
Sharecare, Inc. (NASDAQ: SHCR)
VSEE vs SHCR Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SHCR's P/E ratio is -3.76. In terms of profitability, VSEE's ROE is -4.01%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, VSEE is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
VSEE vs EVH Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, EVH has a market cap of 514M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while EVH trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas EVH's P/E ratio is 35.15. In terms of profitability, VSEE's ROE is -4.01%, compared to EVH's ROE of -1.30%. Regarding short-term risk, VSEE is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check EVH's competition here
Carlsmed, Inc. (NASDAQ: CARL)
VSEE vs CARL Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CARL has a market cap of 396.4M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CARL trades at $14.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CARL's P/E ratio is -10.15. In terms of profitability, VSEE's ROE is -4.01%, compared to CARL's ROE of -0.38%. Regarding short-term risk, VSEE is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CARL's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
VSEE vs SLGC Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SLGC's P/E ratio is -3.04. In terms of profitability, VSEE's ROE is -4.01%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, VSEE is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
VSEE vs SLGCW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, VSEE's ROE is -4.01%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, VSEE is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
VSEE vs TBRG Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas TBRG's P/E ratio is 9.37. In terms of profitability, VSEE's ROE is -4.01%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, VSEE is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check TBRG's competition here
Claritev Corporation (NYSE: CTEV)
VSEE vs CTEV Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CTEV has a market cap of 386.7M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CTEV trades at $22.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CTEV's P/E ratio is -1.34. In terms of profitability, VSEE's ROE is -4.01%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, VSEE is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN)
VSEE vs MPLN Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas MPLN's P/E ratio is -0.23. In terms of profitability, VSEE's ROE is -4.01%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, VSEE is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check MPLN's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
VSEE vs TRHC Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas TRHC's P/E ratio is -4.27. In terms of profitability, VSEE's ROE is -4.01%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, VSEE is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
VSEE vs SY Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SY has a market cap of 268.1M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SY trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SY's P/E ratio is -6.21. In terms of profitability, VSEE's ROE is -4.01%, compared to SY's ROE of -0.16%. Regarding short-term risk, VSEE is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check SY's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
VSEE vs SMFR Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SMFR's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, VSEE is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
VSEE vs SPOK Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SPOK has a market cap of 245.2M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SPOK trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SPOK's P/E ratio is 13.19. In terms of profitability, VSEE's ROE is -4.01%, compared to SPOK's ROE of +0.13%. Regarding short-term risk, VSEE is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
VSEE vs AMWL Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, AMWL has a market cap of 183.9M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while AMWL trades at $11.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas AMWL's P/E ratio is -2.71. In terms of profitability, VSEE's ROE is -4.01%, compared to AMWL's ROE of -0.25%. Regarding short-term risk, VSEE is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check AMWL's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
VSEE vs OPRX Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, OPRX has a market cap of 164.8M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while OPRX trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas OPRX's P/E ratio is 8.03. In terms of profitability, VSEE's ROE is -4.01%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, VSEE is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check OPRX's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
VSEE vs LFMDP Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, LFMDP has a market cap of 145.1M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while LFMDP trades at $21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas LFMDP's P/E ratio is -655.78. In terms of profitability, VSEE's ROE is -4.01%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, VSEE is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check LFMDP's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
VSEE vs CPSI Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CPSI's P/E ratio is -183.80. In terms of profitability, VSEE's ROE is -4.01%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, VSEE is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CPSI's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
VSEE vs DH Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, DH has a market cap of 121.7M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while DH trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas DH's P/E ratio is 4.38. In terms of profitability, VSEE's ROE is -4.01%, compared to DH's ROE of -0.83%. Regarding short-term risk, VSEE is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check DH's competition here
Augmedix, Inc. (NASDAQ: AUGX)
VSEE vs AUGX Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas AUGX's P/E ratio is -4.99. In terms of profitability, VSEE's ROE is -4.01%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, VSEE is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check AUGX's competition here
LifeMD, Inc. (NASDAQ: LFMD)
VSEE vs LFMD Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, LFMD has a market cap of 114.1M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while LFMD trades at $2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas LFMD's P/E ratio is -4.73. In terms of profitability, VSEE's ROE is -4.01%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, VSEE is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check LFMD's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
VSEE vs HCAT Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, HCAT has a market cap of 110.6M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while HCAT trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas HCAT's P/E ratio is 7.35. In terms of profitability, VSEE's ROE is -4.01%, compared to HCAT's ROE of -1.28%. Regarding short-term risk, VSEE is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check HCAT's competition here
CareCloud, Inc. (NASDAQ: CCLD)
VSEE vs CCLD Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CCLD has a market cap of 96.9M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CCLD trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CCLD's P/E ratio is 8.77. In terms of profitability, VSEE's ROE is -4.01%, compared to CCLD's ROE of +0.24%. Regarding short-term risk, VSEE is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CCLD's competition here
Forian Inc. (NASDAQ: FORA)
VSEE vs FORA Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas FORA's P/E ratio is -24.11. In terms of profitability, VSEE's ROE is -4.01%, compared to FORA's ROE of -0.17%. Regarding short-term risk, VSEE is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
VSEE vs CCLDP Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CCLDP's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to CCLDP's ROE of +0.24%. Regarding short-term risk, VSEE is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
VSEE vs SNCE Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SNCE's P/E ratio is -0.27. In terms of profitability, VSEE's ROE is -4.01%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, VSEE is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
VSEE vs AKLI Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas AKLI's P/E ratio is -0.71. In terms of profitability, VSEE's ROE is -4.01%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, VSEE is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
VSEE vs SHLT Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SHLT's P/E ratio is -3.87. In terms of profitability, VSEE's ROE is -4.01%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, VSEE is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
VSEE vs SHCRW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, VSEE's ROE is -4.01%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, VSEE is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMD)
VSEE vs ONMD Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, ONMD has a market cap of 29.7M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while ONMD trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas ONMD's P/E ratio is -31.87. In terms of profitability, VSEE's ROE is -4.01%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, VSEE is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check ONMD's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
VSEE vs STRM Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas STRM's P/E ratio is -2.40. In terms of profitability, VSEE's ROE is -4.01%, compared to STRM's ROE of -0.65%. Regarding short-term risk, VSEE is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
VSEE vs RNLX Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas RNLX's P/E ratio is -0.33. In terms of profitability, VSEE's ROE is -4.01%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, VSEE is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
VSEE vs LIFW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas LIFW's P/E ratio is -0.02. In terms of profitability, VSEE's ROE is -4.01%, compared to LIFW's ROE of +0.81%. Regarding short-term risk, VSEE is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check LIFW's competition here
SCWorx Corp. (NASDAQ: WORX)
VSEE vs WORX Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, WORX has a market cap of 20.6M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while WORX trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas WORX's P/E ratio is -1.50. In terms of profitability, VSEE's ROE is -4.01%, compared to WORX's ROE of -0.35%. Regarding short-term risk, VSEE is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check WORX's competition here
Babylon Holdings Limited (NYSE: BBLN)
VSEE vs BBLN Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas BBLN's P/E ratio is -0.04. In terms of profitability, VSEE's ROE is -4.01%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, VSEE is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check BBLN's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
VSEE vs ONMDW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, ONMDW has a market cap of 9.9M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while ONMDW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas ONMDW's P/E ratio is -0.07. In terms of profitability, VSEE's ROE is -4.01%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, VSEE is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check ONMDW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
VSEE vs ETAO Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas ETAO's P/E ratio is -0.01. In terms of profitability, VSEE's ROE is -4.01%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, VSEE is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
VSEE vs BFRG Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, BFRG has a market cap of 9.6M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while BFRG trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas BFRG's P/E ratio is -1.13. In terms of profitability, VSEE's ROE is -4.01%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, VSEE is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check BFRG's competition here
UpHealth, Inc. (NYSE: UPH-WT)
VSEE vs UPH-WT Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to UPH-WT's ROE of -0.72%. Regarding short-term risk, VSEE is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
VSEE vs UPH Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas UPH's P/E ratio is -0.07. In terms of profitability, VSEE's ROE is -4.01%, compared to UPH's ROE of -1.05%. Regarding short-term risk, VSEE is similarly volatile compared to UPH. This indicates similar risk in terms of short-term price fluctuations for VSEE.Check UPH's competition here
Aclarion, Inc. (NASDAQ: ACON)
VSEE vs ACON Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, ACON has a market cap of 4.9M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while ACON trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas ACON's P/E ratio is -0.19. In terms of profitability, VSEE's ROE is -4.01%, compared to ACON's ROE of -0.63%. Regarding short-term risk, VSEE is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check ACON's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
VSEE vs MGRX Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, MGRX has a market cap of 4.3M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while MGRX trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas MGRX's P/E ratio is -0.14. In terms of profitability, VSEE's ROE is -4.01%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, VSEE is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
VSEE vs PEARW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas PEARW's P/E ratio is -0.00. In terms of profitability, VSEE's ROE is -4.01%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, VSEE is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
VSEE vs PEAR Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas PEAR's P/E ratio is -0.08. In terms of profitability, VSEE's ROE is -4.01%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, VSEE is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check PEAR's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
VSEE vs HCTI Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, HCTI has a market cap of 2.8M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while HCTI trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas HCTI's P/E ratio is -0.47. In terms of profitability, VSEE's ROE is -4.01%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, VSEE is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check HCTI's competition here
Ontrak, Inc. (NASDAQ: OTRK)
VSEE vs OTRK Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas OTRK's P/E ratio is -0.02. In terms of profitability, VSEE's ROE is -4.01%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, VSEE is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
VSEE vs CMAX Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CMAX's P/E ratio is -0.00. In terms of profitability, VSEE's ROE is -4.01%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, VSEE is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
VSEE vs BFRGW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, BFRGW has a market cap of 1.3M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas BFRGW's P/E ratio is -0.22. In terms of profitability, VSEE's ROE is -4.01%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, VSEE is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check BFRGW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
VSEE vs LIFWZ Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to LIFWZ's ROE of +0.81%. Regarding short-term risk, VSEE is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
VSEE vs VSEEW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, VSEE's ROE is -4.01%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, VSEE is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
VSEE vs MSPRZ Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to MSPRZ's ROE of +0.81%. Regarding short-term risk, VSEE is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
VSEE vs KERN Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas KERN's P/E ratio is -0.01. In terms of profitability, VSEE's ROE is -4.01%, compared to KERN's ROE of -0.02%. Regarding short-term risk, VSEE is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
VSEE vs KERNW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas KERNW's P/E ratio is -0.00. In terms of profitability, VSEE's ROE is -4.01%, compared to KERNW's ROE of -0.02%. Regarding short-term risk, VSEE is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
VSEE vs LIFWW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas LIFWW's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to LIFWW's ROE of +0.81%. Regarding short-term risk, VSEE is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
VSEE vs CMAXW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CMAXW's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, VSEE is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
VSEE vs ZCMD Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, ZCMD has a market cap of 16.6K. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while ZCMD trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, VSEE's ROE is -4.01%, compared to ZCMD's ROE of -0.54%. Regarding short-term risk, VSEE is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
VSEE vs ACONW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, ACONW has a market cap of 14.3K. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas ACONW's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to ACONW's ROE of -0.63%. Regarding short-term risk, VSEE is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check ACONW's competition here
NantHealth, Inc. (NASDAQ: NH)
VSEE vs NH Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, NH has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas NH's P/E ratio is -0.12. In terms of profitability, VSEE's ROE is -4.01%, compared to NH's ROE of +0.35%. Regarding short-term risk, VSEE is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check NH's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
VSEE vs SMFRW Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas SMFRW's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, VSEE is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check SMFRW's competition here
Castlight Health, Inc. (NYSE: CSLT)
VSEE vs CSLT Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CSLT has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CSLT's P/E ratio is -37.27. In terms of profitability, VSEE's ROE is -4.01%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, VSEE is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CSLT's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
VSEE vs CNVY Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CNVY has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CNVY's P/E ratio is -71.50. In terms of profitability, VSEE's ROE is -4.01%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, VSEE is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CNVY's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
VSEE vs MSPRV Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas MSPRV's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to MSPRV's ROE of N/A. Regarding short-term risk, VSEE is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for VSEE.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBC)
VSEE vs MTBC Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, MTBC has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas MTBC's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to MTBC's ROE of +0.30%. Regarding short-term risk, VSEE is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check MTBC's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
VSEE vs MTBCP Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas MTBCP's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to MTBCP's ROE of +0.24%. Regarding short-term risk, VSEE is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check MTBCP's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
VSEE vs NAVA Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, NAVA has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas NAVA's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, VSEE is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for VSEE.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
VSEE vs CERN Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CERN has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CERN's P/E ratio is 55.84. In terms of profitability, VSEE's ROE is -4.01%, compared to CERN's ROE of +0.14%. Regarding short-term risk, VSEE is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CERN's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
VSEE vs IMS Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, IMS has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas IMS's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to IMS's ROE of +0.27%. Regarding short-term risk, VSEE is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check IMS's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
VSEE vs MTBCO Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas MTBCO's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to MTBCO's ROE of +0.24%. Regarding short-term risk, VSEE is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check MTBCO's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
VSEE vs AFFX Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, AFFX has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas AFFX's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, VSEE is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check AFFX's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
VSEE vs CHNGU Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CHNGU's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, VSEE is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CHNGU's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
VSEE vs KURIU Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, KURIU has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas KURIU's P/E ratio is N/A. In terms of profitability, VSEE's ROE is -4.01%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, VSEE is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check KURIU's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
VSEE vs CHNG Comparison November 2026
VSee Health, Inc. (NASDAQ: VSEE) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VSEE stands at 931.2K. In comparison, CHNG has a market cap of 0. Regarding current trading prices, VSEE is priced at $1.15 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VSEE currently has a P/E ratio of -2.58, whereas CHNG's P/E ratio is -152.72. In terms of profitability, VSEE's ROE is -4.01%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, VSEE is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for VSEE.Check CHNG's competition here